|
Market Closed -
Euronext Paris
10:25:00 19/11/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 0.2750 EUR | -2.31% |
|
-5.17% | -7.72% |
| 30/10 | Nicox sharply narrows first-half 2026 loss and secures cash runway through 2028 | |
| 30/10 | Nicox S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 2.67Cr 2.93Cr 2.47Cr 2.24Cr 4.2Cr 274.07Cr 4.4Cr 30Cr 12Cr 148.1Cr 11Cr 11Cr 469.13Cr | P/E 2026 * |
-5.5x | P/E 2027 * | 13.8x |
|---|---|---|---|---|---|
| Enterprise Value | 2.67Cr 2.93Cr 2.47Cr 2.24Cr 4.2Cr 274.07Cr 4.4Cr 30Cr 12Cr 148.1Cr 11Cr 11Cr 469.13Cr | EV / Sales 2026 * |
8.91x | EV / Sales 2027 * | 2.67x |
| Free-Float |
96.11% | Yield 2026 * |
-
| Yield 2027 * | - |
Euronext ParisEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| ALCOX | Real-time | |
| COXp | Real-time | ||
| NXOA | Delayed | ||
| 0RCQ | Real-time | ||
| NXOA | Delayed | ||
| NXOA | Real-time |
| 1 day | -2.31% | ||
| 1 week | -5.17% | ||
| Current month | -8.03% | ||
| 1 month | -7.41% | ||
| 3 months | -28.39% | ||
| 6 months | -28.29% | ||
| Current year | -7.72% |
| 1 week | 0.28 | 0.29 | |
| 1 month | 0.28 | 0.32 | |
| Current year | 0.28 | 0.57 | |
| 1 year | 0.28 | 0.57 | |
| 3 years | 0.14 | 0.65 | |
| 5 years | 0.14 | 3.14 | |
| 10 years | 0.14 | 13.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gavin Spencer
CEO | Chief Executive Officer | 55 | 28/02/2024 |
Sandrine Gestin
DFI | Director of Finance/CFO | 58 | 01/01/2015 |
Emmet Purtill
PRN | Corporate Officer/Principal | - | 01/01/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
Gavin Spencer
BRD | Director/Board Member | 55 | 08/04/2024 |
Damian Marron
CHM | Chairman | 64 | 16/07/2024 |
Marc Bozec
BRD | Director/Board Member | - | 16/07/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 29/01/22 | Free | Chief Executive Officer | 15,000 | 0.0348% | ||
| 16/02/21 | Exercice | Chief Executive Officer | 10,000 | 0.0270% | ||
| 01/02/20 | Free | Chief Executive Officer | 10,000 | 0.0300% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.31% | -5.17% | -12.56% | -33.41% | 3Cr | ||
| -2.29% | -5.34% | +28.73% | +128.34% | 1,23200Cr | ||
| -2.04% | -5.78% | +31.91% | +78.34% | 66TCr | ||
| -0.86% | -3.71% | +21.74% | +105.02% | 51TCr | ||
| -1.04% | -1.80% | +28.69% | +68.01% | 38TCr | ||
| -3.61% | -9.62% | +39.73% | +30.53% | 34TCr | ||
| -3.22% | -5.20% | +24.48% | +51.30% | 29TCr | ||
| -2.51% | -4.49% | -2.15% | +29.67% | 28TCr | ||
| -1.14% | -6.05% | +28.16% | +65.35% | 24TCr | ||
| -1.45% | -0.85% | +30.03% | +120.72% | 21TCr | ||
| Average | -2.05% | -2.59% | +21.88% | +64.39% | 41TCr | |
| Weighted average by Cap. | -2.04% | -2.67% | +26.93% | +87.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 30L 32.93L 27.77L 25.12L 47.12L 31Cr 49.32L 3.36Cr 1.33Cr 17Cr 1.24Cr 1.21Cr 53Cr | 1Cr 1.1Cr 92.57L 83.73L 1.57Cr 102.51Cr 1.64Cr 11Cr 4.44Cr 55Cr 4.12Cr 4.03Cr 175.46Cr |
| Net income | -50L -54.88L -46.28L -41.87L -78.54L -51Cr -82.2L -5.59Cr -2.22Cr -28Cr -2.06Cr -2.02Cr -88Cr | 20L 21.95L 18.51L 16.75L 31.42L 21Cr 32.88L 2.24Cr 88.77L 11Cr 82.36L 80.63L 35Cr |
| Net Debt | - | - |
Employees
5
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/26/19 | €0.2750 | -2.31% | 1,51,106 |
| 18/26/18 | €0.2815 | -0.18% | 2,28,494 |
| 17/26/17 | €0.2820 | -1.40% | 81,691 |
| 16/26/16 | €0.2860 | -0.35% | 42,063 |
| 13/26/13 | €0.2870 | -1.03% | 82,753 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.2750EUR
Average target price
1.000EUR
Spread / Average Target
+263.64%
- Stock Market
- Stocks
- ALCOX Stock
Select your edition
All financial news and data tailored to specific country editions
















